Cambridge Healthtech Institute’s 4th Annual
Emerging Immune Modulation Strategies
New Methodologies and Modalities for Profiling and Modulating Immune Responses
September 22, 2025
There is increased awareness and heightened interest in learning more about the role of immune responses in diseases like cancer, neurodegeneration, fibrosis, autoimmune disorders, and more. Cambridge Healthtech Institute’s symposium on Emerging Immune Modulation Strategies highlights techniques and drug modalities being used to understand and target immune pathways and responses for drug discovery and therapy.
Coverage will include, but is not limited to:
- Next-generation small molecule immunomodulatory drugs
- Rise of bispecifics and antibody drug conjugates (ADCs) for immune modulation
- Exploring oligonucleotides, gene editing, and cell therapy for immunotherapy
- Techniques for studying immune responses in the brain and the tumor microenvironment
- Single cell RNA sequencing, spatial biology, imaging tools for studying immune responses
- Phenotypic assays and 3D models for monitoring immune-related changes
- Immunophenotyping for exploration of novel therapeutics
- Use of artificial intelligence and machine learning for predicting immune responses
- Clinical landscape of immunomodulatory drugs and biomarkers of clinical utility
- Safety challenges of immune activators and suppressors
The deadline for priority consideration is March 7, 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: